GCM
EXAS

Graham Capital Management’s Exact Sciences EXAS Stock Holding History

Graham Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,039
Closed -$604K – 1332
2025
Q3 		$604K Sell
11,039
-26,478
-71% -$1.32M 0.01% 550
2025
Q2 		$1.99M Buy
37,517
+25,514
+213% +$1.3M 0.03% 358
2025
Q1 		$520K Buy
+12,003
New +$608K 0.01% 790
2024
Q3 		– Sell
-4,997
Closed -$211K – 1165
2024
Q2 		$211K Sell
4,997
-6,094
-55% -$335K ﹤0.01% 848
2024
Q1 		$766K Buy
11,091
+4,785
+76% +$303K 0.01% 494
2023
Q4 		$467K Sell
6,306
-295
-4% -$19.3K 0.01% 613
2023
Q3 		$450K Sell
6,601
-742
-10% -$63K 0.01% 592
2023
Q2 		$690K Buy
+7,343
New +$573K 0.02% 467
2022
Q3 		– Sell
-19,550
Closed -$770K – 1131
2022
Q2 		$770K Buy
+19,550
New +$1.05M 0.03% 519

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Graham Capital Management's EXAS Position: Q4 2025 in Review

Graham Capital Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 11,039 shares — an estimated $604K sold.

Graham Capital Management first reported a position in EXAS in Q2 2022 and held it in 9 quarters. The position peaked at $1.99M in Q2 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Graham Capital Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 11,039 Exact Sciences shares in Q4 2025, an estimated $604K.
  • Graham Capital Management first reported a position in Exact Sciences in Q2 2022 and held it in 9 quarters.
  • Graham Capital Management's Exact Sciences position peaked at $1.99M in Q2 2025.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.